The device is also authorized for dystonia in Europe.

Dr. The device is also authorized for dystonia in Europe. ‘We are thrilled to be the 1st institution in the United States to provide Activa SC, an important new technology that significantly enhances our capability to treat and customize therapy for a large group of our patients,’ said Simpson. ‘We have a greater ability to fine-tune stimulation and customize our patients’ therapy, which might help us deal with their disease more efficiently and in a shorter period of time. KlegermanThe Activa SC program is comprised of an implantable neurostimulator; a thin, insulated lead that’s placed in a specific target within the mind; and an extension for connecting the neurostimulator and the business lead.Pelaez says.. Accelovance opens new workplace in Research Triangle Recreation area, North Carolina Accelovance, a therapeutically focused clinical study organization , announced today the opening of a new office in Study Triangle Park , North Carolina. This office opening works with continued corporate expansion and provides Accelovance's employees and clients with a presence in the research-active landscape of the RTP region of North Carolina. The brand new offices are close to many current and clients and provide a rich bottom of technical skill to support continued corporate development. Building and scaling a high-quality team is a key driver to our continued success as a business, said Stephen Trevisan, CEO and President.